Regular inspection can greatly reduce the risk of diabetic foot ulcers, but for many it’s a challenge. That’s why we developed an easy at-home method.
Many people with diabetes develop peripheral neuropathy, a condition that impacts feeling in their feet. This leads to greater risk of foot damage going unnoticed, which in turn may result in challenging diabetic foot ulcers (DFUs).
Up to 25% of people with diabetes will develop a DFU requiring medical attention
40% of those who experience a DFU will have another within a year
The cost to US healthcare is over $17B annually
Up to 10% of DFUs can result in amputation; post-amputation mortality within 1–5 years is higher than many forms of cancer.
Many individuals can’t inspect their own feet daily due to practical challenges such as flexibility, vision impairment, risk understanding.
An at home “smart scale” that scans feet in less than 30 seconds per day. Every scan collects hi-res image & temperature analysis.
A monitoring service that identifies and communicates risks to users and when necessary, their physicians.
Bluedrop is designed to make checking your feet at home on a daily basis easier. Follow the link below to find the more information.
Bluedrop can help minimize the effort associated with caring for your highest risk patients. We provide direct patient engagement to ensure you see issues only when they require medical attention.
At Bluedrop, we rely on a simple proven principle to drive results – early detection can lead to timely intervention that reduces clinical severity and cost. We achieve this by capturing consistent and accurate image and temperature data with every device use. This combination of data provides the right insight to know how and when to engage patients, limiting unnecessary alerts that can discourage use of any monitoring system over time.
Additionally, we “see” risks as they occur and can communicate specifically with patients, and if necessary, their providers, to take appropriate action. As such, we see an average use across all patients of ~4 scans / week, with the few ulcers that are detected graded at a Stage 1 at time of clinical escalation.
Ease of Use + Timely Insight
= Better Outcomes
A DFU identified and addressed early (Stage 1) costs significantly less to treat than a more severe DFU.
57% less than Stage 2
85% less than Stage 3
93% less than Stage 4 and 5
Bluedrop gives patients and providers a faster, simpler way to stay ahead of foot-health complications.